NHS chief Simon Stevens will today announce that NHS England has struck deals to make innovative treatments for Multiple Sclerosis and breast cancer routinely available on the NHS. From tomorrow (10 November) hundreds of patients with Multiple Sclerosis are set to benefit from a new treatment option, Mavenclad, following a deal with drug company Merck. […]
The NHS is on-track to transform cancer services in England by 2020/21 according to a report published today by NHS England’s National Cancer Programme. The report details the investment the NHS is making in cancer transformation, including £130m over the period 2016/18 in new and upgraded radiotherapy equipment and £200m over the next two years […]
A major NHS England funded study is expected to almost halve the number of invasive procedures by 2020 by improving the accuracy of home-testing kits that detect bowel cancer from invisible amounts of blood. This could mean more than 100,000 NHS patients in England avoid the need for uncomfortable colonoscopies each year by first getting […]
In a world leading move, quality of life for cancer patients will be tracked as part of ambitious plans by NHS England to radically improve care and support for people once treatment ends. The ground-breaking new approach is set to drive improvements in after care which includes personalised plans for people with cancer outlining not […]
An annual national survey published today shows key patient experiences of NHS cancer care improved over the past year. The National Cancer Patient Experience Survey 2016 asked people with cancer across England for their views on their care, with 72,788 responding. Asked to rate their care on a scale of zero (very poor) to 10 […]
A state of the art proton beam therapy machine, the ‘cyclotron’, will be installed at the specialist cancer hospital The Christie in Manchester today, marking a major milestone in a national NHS plan to provide high energy proton beam therapy in the UK from next year. Proton beam therapy has been offered overseas to NHS […]
NHS chief Simon Stevens has today announced that NHS England has struck a deal with Roche, also endorsed by NICE, to make the breast cancer drug Kadcyla available for routine use on the NHS. Speaking at the NHS Confederation conference in Liverpool, Simon Stevens said: “NHS cancer survival rates are now at record highs, and this […]
Within two years, over 5,000 more people a year will survive cancer, meaning the NHS is on track to meet the ambitions of the cancer taskforce thanks to better prevention, earlier diagnosis and innovative new treatments for cancer. Cancer survival rates are at a record high, with an estimated 7,000+ more people surviving cancer after […]
2,400 more cancer survivors over past year thanks to improved NHS cancer care. NHS England’s chief executive Simon Stevens will today (Tuesday) announce the first wave of hospitals to benefit from a major national investment in NHS radiotherapy machines alongside £200m of funding over two years to improve local cancer services. Speaking at the Britain […]
NHS England chief executive Simon Stevens has today (Tuesday) announced a £130m investment to kickstart the upgrade of radiotherapy equipment and transform cancer treatment across England. Around 4 in 10 of all NHS cancer patients are treated with radiotherapy, which typically uses high-energy radiation from a machine called a linear accelerator (‘Linac’). Radiotherapy is one […]